Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SNPs Study of DPP4 and GLP1R in Chinese and Its Application in Blood Glucose Regulation With Incretin
ChiCTR-OPN-17011066Phase 4Recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Mar 2016
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sitagliptin and liraglutide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoints: HbA1c, glycated albumin and 2 more. Started Mar 2016; status: recruiting.
02
Drugs
sitagliptinliraglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR-OPN-17011066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-17011066.